import Navbar from '@/components/Navbar';
import Footer from '@/components/Footer';
import { Link } from 'react-router-dom';
import { SEOHead } from '@/components/seo/SEOHead';
import { BreadcrumbNav } from '@/components/seo/BreadcrumbNav';
import { FAQSection } from '@/components/healthcare-research/FAQSection';
import { buildBreadcrumbSchema } from '@/lib/seo/schemas';
import { ArrowRight } from 'lucide-react';
import { getStandaloneReportConfig } from '@/data/reportConversionConfig';
import { MarketIntelligenceSections } from '@/components/market-intelligence';
import { buildReportEnrichmentSchemas } from '@/lib/reportEnrichmentSchemas';
import {
  ReportConsultationBand,
  ReportContentWithAside,
  ReportEarlyCtaBar,
  ReportMidPageCta,
  ReportReadingProgress,
} from '@/components/report-conversion';

const breadcrumbItems = [
  { name: 'Home', href: '/' },
  { name: 'Kuwait Healthcare Market Report', href: '/kuwait-healthcare-market-report' },
];

const REPORT_FAQ_ITEMS = [
  {
    question: 'How big is the Kuwait healthcare market in 2026?',
    answer:
      'The Kuwait healthcare market is estimated at USD 7.5–8.5 billion in 2026, with government expenditure accounting for approximately 78% of total spending. Kuwait allocates around 5–6% of GDP to healthcare — one of the GCC\'s higher ratios — though per-capita spending trails Saudi Arabia and UAE due to infrastructure bottlenecks. The market is projected to reach USD 11–13 billion by 2030, driven by privatization, chronic disease management investment, and capacity expansion.',
  },
  {
    question: 'What is the Kuwait pharmaceutical market size in 2026?',
    answer:
      'The Kuwait pharmaceutical market is estimated at USD 950M–1.1 billion in 2026. Approximately 85% of pharmaceutical spend flows through MOPH Central Medical Stores procurement. Generic drugs dominate by volume (over 70%), but branded specialty pharmaceuticals — particularly in oncology, immunology, and diabetes — represent the highest-value segments. Kuwait imports 95%+ of pharmaceutical requirements, creating strong demand for registered products across all major therapeutic areas.',
  },
  {
    question: 'What are the main challenges for pharmaceutical market access in Kuwait?',
    answer:
      'Kuwait market access presents three core challenges: (1) Central Medical Stores procurement concentration — winning CMS registration and tender listing is the primary access gate, as CMS supplies all government hospitals; (2) Generic substitution pressure — CMS tender criteria heavily weight price, requiring robust health-economic justification for branded products; (3) Long registration timelines — MOPH drug registration typically requires 18–30 months. BioNixus maps Kuwait MOPH registration pathways, CMS formulary listing requirements, and payer evidence expectations.',
  },
  {
    question: 'How is Kuwait healthcare changing under Kuwait Vision 2035?',
    answer:
      'Kuwait Vision 2035\'s healthcare pillar targets a 30% private sector healthcare share (up from ~15% currently), construction of 11 new government hospitals, and development of a medical tourism hub in Kuwait Bay. The Jaber Al-Ahmad Hospital expansion and Sabah Al-Ahmad Medical City are the two largest infrastructure projects. Telemedicine and digital health regulation is evolving, and private health insurance penetration is rising — gradually shifting the procurement landscape away from purely CMS-centralized access.',
  },
  {
    question: 'Which therapy areas are growing fastest in Kuwait?',
    answer:
      'The fastest-growing therapy areas in Kuwait are oncology (driven by Kuwait Cancer Center and Chest Disease Hospital expansion), diabetes and metabolic disease (~25% adult diabetes prevalence — treatment intensification is a priority), rare diseases (genetic disease burden is high in Kuwait\'s consanguineous population), and immunology/biologics. Cardiovascular disease remains the leading cause of mortality and the largest pharmaceutical spend category by volume.',
  },
  {
    question: 'How does BioNixus conduct Kuwait healthcare market research?',
    answer:
      'BioNixus conducts Kuwait healthcare market research through quantitative physician surveys across specialist panels (oncology, endocrinology, cardiology, rheumatology, neurology), CMS tender and formulary tracking, qualitative interviews with MOPH payer contacts, and hospital procurement intelligence from key accounts including Mubarak Al-Kabeer Hospital, Amiri Hospital, Jaber Hospital, and leading private facilities. Our Kuwait research team has operated in-country since 2015, maintaining specialist physician panels used by global pharmaceutical companies for launch readiness and competitive intelligence studies.',
  },
];

const REPORT_CONVERSION = getStandaloneReportConfig('/kuwait-healthcare-market-report');
const FAQ_SECTION_ID = 'kuwait-healthcare-market-faq';

const jsonLd = [
  buildBreadcrumbSchema(breadcrumbItems),
  {
    '@context': 'https://schema.org',
    '@type': 'Article',
    headline: 'Kuwait Healthcare Market Report 2026: Pharma, Medical Devices, and Market Access Intelligence',
    author: { '@type': 'Organization', name: 'BioNixus' },
    publisher: {
      '@type': 'Organization',
      name: 'BioNixus',
      logo: { '@type': 'ImageObject', url: 'https://www.bionixus.com/bionixus-logo.webp' },
    },
    datePublished: '2026-05-27',
    dateModified: '2026-05-27',
    mainEntityOfPage: 'https://www.bionixus.com/kuwait-healthcare-market-report',
  },
  {
    '@context': 'https://schema.org',
    '@type': 'FAQPage',
    url: `https://www.bionixus.com/kuwait-healthcare-market-report#${FAQ_SECTION_ID}`,
    mainEntity: REPORT_FAQ_ITEMS.map((item) => ({
      '@type': 'Question',
      name: item.question,
      acceptedAnswer: { '@type': 'Answer', text: item.answer },
    })),
  },
  ...buildReportEnrichmentSchemas({
    pageTitle: "Kuwait Healthcare Market Report 2026 | Pharma, Medical Devices & Market Access | BioNixus",
    pageMetaDescription: "Kuwait healthcare market at USD 7.5–8.5B in 2026. Pharmaceutical market (USD 1B), CMS procurement intelligence, MOPH registration, therapy area analysis, and primary HCP research from BioNixus.",
    countryName: "Kuwait",
    marketSlug: "kuwait",
    publishedDate: "2026-05-27",
    modifiedDate: "2026-05-27",
  })
];

const KuwaitHealthcareMarketReport = () => {
  return (
    <div className="min-h-screen bg-background">
      <Navbar />
      <SEOHead
        title="Kuwait Healthcare Market Report 2026 | Pharma, Medical Devices & Market Access | BioNixus"
        description="Kuwait healthcare market at USD 7.5–8.5B in 2026. Pharmaceutical market (USD 1B), CMS procurement intelligence, MOPH registration, therapy area analysis, and primary HCP research from BioNixus."
        canonical="https://www.bionixus.com/kuwait-healthcare-market-report"
        jsonLd={[...jsonLd, ...buildReportEnrichmentSchemas({
    pageTitle: "Kuwait Healthcare Market Report 2026 | Pharma, Medical Devices & Market Access | BioNixus",
    pageMetaDescription: "Kuwait healthcare market at USD 7.5–8.5B in 2026. Pharmaceutical market (USD 1B), CMS procurement intelligence, MOPH registration, therapy area analysis, and primary HCP research from BioNixus.",
    countryName: "Kuwait",
    marketSlug: "kuwait",
    publishedDate: "2026-05-27",
    modifiedDate: "2026-05-27",
  })]}
      />
      <ReportReadingProgress progressId="report-rp-kuwait-healthcare-market-report" />
      <main>
        <div className="section-padding pt-24 pb-4">
          <div className="container-wide"><BreadcrumbNav items={breadcrumbItems} /></div>
        </div>

        <section className="section-padding pb-10">
          <div className="container-wide max-w-4xl mx-auto">
            <div className="inline-flex items-center gap-2 px-4 py-2 rounded-full bg-primary/10 text-primary text-xs font-medium mb-6">
              Published by BioNixus · Updated May 2026 · Open access
            </div>
            <h1 className="text-3xl md:text-5xl font-display font-bold text-foreground mb-6">
              Kuwait Healthcare Market Report 2026: Pharmaceutical Intelligence, Medical Devices, and Market Access
            </h1>
            <p className="text-muted-foreground leading-relaxed">
              BioNixus delivers Kuwait pharmaceutical consumption data, CMS procurement intelligence, physician
              panel research, and market access mapping — covering all major therapeutic areas and hospital
              accounts across Kuwait's government and private healthcare systems.
            </p>
            <ReportEarlyCtaBar config={REPORT_CONVERSION} className="mt-8" />
          </div>
        </section>

        <ReportContentWithAside config={REPORT_CONVERSION} containerClassName="container-wide max-w-6xl mx-auto section-padding">
        <section className="section-padding bg-cream-dark" id="executive-summary">
          <div className="container-wide max-w-4xl mx-auto">
            <h2 className="text-2xl md:text-3xl font-display font-semibold text-foreground mb-6">Executive Summary</h2>
            <div className="bg-white rounded-xl border border-border p-6 shadow-sm mb-6">
              <div className="grid sm:grid-cols-3 gap-6 text-center">
                <div><p className="text-3xl font-display font-bold text-primary">~$8B</p><p className="text-xs text-muted-foreground mt-1">Kuwait healthcare market 2026</p></div>
                <div><p className="text-3xl font-display font-bold text-primary">~$1B</p><p className="text-xs text-muted-foreground mt-1">Pharmaceutical market 2026</p></div>
                <div><p className="text-3xl font-display font-bold text-primary">5.2%</p><p className="text-xs text-muted-foreground mt-1">CAGR 2026–2030</p></div>
              </div>
            </div>
            <p className="text-muted-foreground leading-relaxed mb-4">
              Kuwait operates one of the GCC's most centralized healthcare procurement systems. The Ministry of
              Public Health funds universal healthcare for all Kuwaiti nationals and subsidized care for residents,
              creating a single dominant procurement channel through Central Medical Stores. This structure provides
              commercial teams with a highly concentrated access target — but also means that access decisions cascade
              across all government facilities simultaneously.
            </p>
            <p className="text-muted-foreground leading-relaxed mb-4">
              Kuwait's disease burden is structurally challenging: diabetes prevalence (~25%), obesity rates among
              the world's highest, and cardiovascular disease as the leading cause of mortality create persistent
              demand for chronic disease management products. Rare genetic diseases are also disproportionately
              prevalent due to historically high consanguinity rates.
            </p>
            <p className="text-muted-foreground leading-relaxed">
              See also:{' '}
              <Link to="/kuwait-market-access-research" className="text-primary hover:underline font-medium">
                Kuwait Market Access Research
              </Link>
              {' '}and{' '}
              <Link to="/kuwait-medical-devices-market-report" className="text-primary hover:underline font-medium">
                Kuwait Medical Devices Market Report
              </Link>.
            </p>
            <ReportMidPageCta config={REPORT_CONVERSION} className="mt-8" />
          </div>
        </section>

        <MarketIntelligenceSections marketSlug="kuwait" countryName="Kuwait" variant="healthcare" />

        <section className="section-padding" id="therapy-areas">
          <div className="container-wide max-w-4xl mx-auto">
            <h2 className="text-2xl md:text-3xl font-display font-semibold text-foreground mb-8">
              Kuwait Pharmaceutical Therapy Area Overview
            </h2>
            <div className="space-y-4">
              {[
                { area: 'Oncology', detail: 'Kuwait Cancer Center is the primary oncology treatment hub. Growing procedural volume is driving infusion drug demand and specialist physician panel depth. BioNixus maintains an oncologist panel in Kuwait for prescribing behavior and formulary access research.' },
                { area: 'Diabetes & Metabolic Disease', detail: 'Kuwait\'s ~25% adult diabetes prevalence makes this the largest volume pharmaceutical category. GLP-1 receptor agonist adoption is accelerating. BioNixus tracks insulin, oral antidiabetic, and GLP-1 prescribing at physician and account level.' },
                { area: 'Cardiovascular', detail: 'CVD is Kuwait\'s leading cause of mortality. Lipid management, antihypertensives, and anticoagulants represent the largest pharmaceutical spend segment. Interventional cardiology volumes growing at Jaber Al-Ahmad and Amiri hospitals.' },
                { area: 'Rare Diseases & Genetics', detail: 'Kuwait\'s genetic disease burden — including various storage disorders, sickle cell, and familial hypercholesterolaemia — creates a concentrated rare disease market. Patient-level consumption data at KFSH&RC-Kuwait and specialty centers is essential for orphan drug programs.' },
                { area: 'Immunology & Biologics', detail: 'Biologic adoption in rheumatology and inflammatory bowel disease is growing. Biosimilar penetration is lower than Saudi Arabia or UAE — branded biologics retain strong market position supported by specialist preference and CMS formulary inertia.' },
              ].map(({ area, detail }) => (
                <div key={area} className="bg-white rounded-xl border border-border p-5 shadow-sm">
                  <h3 className="text-base font-semibold text-foreground mb-2">{area}</h3>
                  <p className="text-sm text-muted-foreground leading-relaxed">{detail}</p>
                </div>
              ))}
            </div>
          </div>
        </section>

        <FAQSection sectionId={FAQ_SECTION_ID} title="Kuwait healthcare market 2026 — pharma, CMS procurement, and market access FAQ" items={REPORT_FAQ_ITEMS} className="bg-muted/30" />
        </ReportContentWithAside>
        <ReportConsultationBand config={REPORT_CONVERSION} />
        </main>
      <Footer />
    </div>
  );
};

export default KuwaitHealthcareMarketReport;
